Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Imaging Technique May Show Alzheimer's Progression
Aug 1999
CAMBRIDGE, Mass., Aug. 11 -- A team of scientists at the Harvard Institutes of Medicine is working to develop a non-invasive method to image plaque deposits in the brains of patients with Alzheimer's disease as the disease progresses. To date, the only definitive means of diagnosing both the plaque formation and the disease itself has been a posthumous examination of the patient's brain. The Harvard studies were described in the July 29 issue of the Journal of Medicinal Chemistry.
The technique involves coupling an isotope of the element technetium to large organic molecules that are known to have an affinity for the type of amyloid present in the brain of a patient with Alzheimer's disease. The imaging is then done with single-photon computed tomography, which detects gamma particles emitted by the trace amounts of radioactive technetium probe. Laboratory studies are in progress.

Basic ScienceNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.